# Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

> **NCT03245177** · PHASE1 · WITHDRAWN · sponsor: **Prof Corinne Faivre-Finn**

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** Pembrolizumab
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT03245177
- **Lead sponsor:** Prof Corinne Faivre-Finn
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-08
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding withdrawn.
- **Last updated:** 2021-07-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03245177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03245177, "Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03245177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*